A-9
TEST (SAMPLE)
REFERENCE VALUES:
CONVENTIONAL (SI)
PHYSIOLOGICAL INDICATION AND CLINICAL IMPLICATIONS
Blood Chemistry Studies
Ammonia (P)
15–120 μg/dl
(9–70 μmol/L)
Liver and renal function. Increased values in liver disease, renal
failure, newborn hemolytic disease, heart failure, cor pulmonale.
Decreased values in hypertension.
Amylase (S)
56–190 IU/L
(0.4–2.1 μkat/L)
Pancreatic function. Increased values in pancreatitis, mumps,
obstruction of pancreatic duct, ketoacidosis. Decreased values
in kidney disease, pancreatic damage or cancer, toxemia of
pregnancy.
Aspartate aminotransferase
(AST, or SGOT) (S)
#
40 IU/L
(
#
0.7 μkat/L)
Cellular damage. Increased after myocardial infarction, acute
liver disease, drug toxicity, muscle trauma. Decreased in
pyridoxine (vitamin B
6
) deficiency.
Bilirubin (S)
Total: 0.1–1.0 mg/dl
(1.7–17.1 μmol/L)
Direct:
,
0.4 mg/dl
(
,
6.8 μmol/L)
Indirect: 0.1–1.0 mg/dl
(1.7–17.1 μmol/L)
Newborn:
,
13.0 mg/dl
(
,
222 μmol/L)
Liver function and red cell breakdown. Increased levels of direct
in liver disease and biliary obstruction. Increased levels of indirect
in hemolysis of red blood cells.
Blood urea nitrogen (S)
7–26 mg/dl
(2.5–9.3 mmol/L)
Kidney function. Increased values in renal disease, dehydration,
urinary obstruction, congestive heart failure, myocardial
infarction, burns. Decreased values in liver failure, overhydration,
impaired protein absorption, pregnancy.
Cholesterol
,
200 mg/dl
(
,
5.2 mmol/L)
Metabolism—fat utilization. Increased values in diabetes mellitus,
pregnancy, use of oral contraceptives or anabolic steroids.
High-density lipoprotein (HDL)
cholesterol (S)
20–30% of total
.
40 mg/dl
(
.
1.0 mmol/L)
Increased levels in liver disease, aerobic exercise. Decreased levels
in atherosclerotic heart disease, malnutrition.
Low-density lipoprotein (LDL)
cholesterol (S)
60–70% of total
,
130 mg/dl
(
,
3.4 mmol/L)
Increased values in hyperlipidemia, atherosclerotic heart disease.
Decreased values in fat malabsorption and malnutrition.
Very low density lipoprotein
cholesterol (VLDL) (S)
10–15% of total
Same as LDL.
Creatine kinase (CK) (S)
Female:
#
190 U/L
(
#
3.2 μkat/L)
Male:
#
235 U/L
(
#
3.9 μkat/L)
Cellular damage. Increased values in myocardial infarction,
muscular dystrophy, hypothyroidism, pulmonary infarction,
cerebrovascular accident (CVA), shock, tissue damage, and
trauma.
Creatinine (S)
0.5–1.2 mg/dl
(44–106 μmol/L)
Renal function. Increased values in renal disease and acromegaly.
Decreased in muscular dystrophy.
Appendix F
Reference Values for Selected Blood and Urine Studies
The reference values listed for the selected blood and urine studies
are common ranges for adults, but specific “normals” are estab-
lished by the laboratory performing the analysis. The values may be
affected by a wide range of circumstances, including testing meth-
ods and equipment used, client age, body mass, sex, diet, activity
level, medications, and extent of disease processes.
Reference values are identified in both standard or conventional
units and in the system of international (SI) units. SI units (given in
parentheses) are measurements of amount per volume and are used
in most countries and scientific journals. SI units are often given as
moles or millimoles per liter. Most clinical laboratories and textbooks
in the United States use conventional or standard units, which mea-
sure mass per volume. These values are given as grams, milligrams,
or milliequivalents per deciliter or liter. It is anticipated that the
United States will eventually use SI units exclusively.
For enzymes, 1 international unit (IU) represents an arbitrary but
defined amount of activity, whereas 1 katal (kat) is the amount of
enzyme required to consume 1 mol of substrate per second.
Sample types in column 1 are serum (S), plasma (P), arterial
whole blood (A), and whole blood (WB).
previous page 1151 Human Anatomy and Physiology (9th ed ) 2012 read online next page 1153 Human Anatomy and Physiology (9th ed ) 2012 read online Home Toggle text on/off